Let’s Take a Look at Brainstorm Cell Therapeutics Inc. (BCLI) Stock

Brainstorm Cell Therapeutics Inc. (BCLI) share price plummeted -9.35% with the closing price of $13.86 on Friday. Brainstorm Cell Therapeutics Inc. stock has an exchanging volume of 0.92 million shares, which is high, contrasted with its 3-months average volume of 502.32K shares. Its market capitalization has now reached to $441.44M and analysts have a consensus target price of $22.33 in the 12-month period.

BrainStorm Announces Financial Results for the Third Quarter of 2020 and Provides a Corporate Update on October 15, 2020 news published at Yahoo.

BrainStorm Cell Therapeutics Inc. (BCLI) announced financial results for the third quarter ended September 30, 2020. Cash and cash equivalents, and short-term bank deposits amounted to approximately $28.8 million at September 30, 2020 compared to $16.2 million at June 30, 2020.

Research and development expenses, net for the three months ended September 30, 2020 and 2019 were $1.87 million and $4.01 million, respectively.

General and administrative expenses for the three months ended September 30, 2020 and 2019 were $2.62 million and $1.54 million, respectively.

Net loss for the three months ended on September 30, 2020 was $4.49 million, as compared to a net loss of $5.63 million for the three months ended September 30, 2019.

BCLI Past Trading Activity

The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, BCLI price has dropped by -21.03%. In the course of past three months sees the stock go down around -10.41%, while it has gain 122.47% over the past six months and 223.83% since the start of the year.

BCLI Earning History

Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), Brainstorm Cell Therapeutics Inc. posted -$0.25 earnings per share (EPS) which was above the consensus estimate of -$0.26 by $0.01, which represents to an expansion by 3.80%.

BCLI Price Performance

Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Brainstorm Cell Therapeutics Inc. has seen its stock exchanging -22.79% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +22.03% above its three-month low. A more extensive look sees BCLI exchanging -22.79% beneath its 52-week high and 287.15% above from its 52-week low price.

BCLI Instability & Beta Factor

The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 9.06%, while it has a month to month instability of 6.97%. The company has an ATR (Average True Range) of 1.07 and a beta factor of 0.75.

Leave a Comment